Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -49.3x - -54.4x | -51.9x |
| Selected Fwd P/E Multiple | -49.6x - -54.8x | -52.2x |
| Fair Value | $0.045 - $0.050 | $0.048 |
| Upside | -52.6% - -47.6% | -50.1% |
| Benchmarks | - | Full Ticker |
| Creo Medical Group PLC | - | OTCPK:CMEO.F |
| Abingdon Health Plc | - | AIM:ABDX |
| EKF Diagnostics Holdings plc | - | OTCPK:EKDH.F |
| ANGLE plc | - | OTCPK:ANPC.F |
| NIOX Group Plc | - | OTCPK:CSSP.F |
| Deltex Medical Group plc | - | OTCPK:DTXM.F |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| CMEO.F | ABDX | EKDH.F | ANPC.F | CSSP.F | DTXM.F | |||
| OTCPK:CMEO.F | AIM:ABDX | OTCPK:EKDH.F | OTCPK:ANPC.F | OTCPK:CSSP.F | OTCPK:DTXM.F | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | 11.2% | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | -26.7% | NM- | 13.9% | NM- | ||
| Latest Twelve Months | -28.1% | -14.8% | 165.4% | 29.3% | -64.2% | -26.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -19904.9% | -206.9% | 7.5% | -1343.0% | -18.2% | -38.7% | ||
| Prior Fiscal Year | -70.5% | -85.8% | 4.5% | -921.0% | 25.8% | -46.1% | ||
| Latest Fiscal Year | -695.0% | -20.7% | 12.4% | -497.0% | 8.1% | -72.2% | ||
| Latest Twelve Months | -695.0% | -37.9% | 12.4% | -497.0% | 8.1% | -72.5% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -2.1x | -10.7x | 9.9x | -1.4x | 24.4x | -208.7x | ||
| Price / LTM Sales | 15.1x | 3.6x | 2.2x | 9.0x | 6.6x | 75.3x | ||
| LTM P/E Ratio | -2.2x | -9.4x | 18.0x | -1.8x | 81.6x | -103.8x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -9.4x | -1.8x | 81.6x | |||||
| Historical LTM P/E Ratio | -47.3x | -15.3x | -1.6x | |||||
| Selected P/E Multiple | -49.3x | -51.9x | -54.4x | |||||
| (x) LTM Net Income | (1) | (1) | (1) | |||||
| (=) Equity Value | 64 | 67 | 70 | |||||
| (/) Shares Outstanding | 1,896.0 | 1,896.0 | 1,896.0 | |||||
| Implied Value Range | 0.03 | 0.04 | 0.04 | |||||
| FX Rate: GBP/USD | 0.7 | 0.7 | 0.7 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.05 | 0.05 | 0.05 | 0.10 | ||||
| Upside / (Downside) | -52.6% | -50.1% | -47.6% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CMEO.F | ABDX | EKDH.F | ANPC.F | CSSP.F | DTXM.F | |
| Value of Common Equity | 55 | 24 | 121 | 26 | 258 | 134 | |
| (/) Shares Outstanding | 402.5 | 375.9 | 515.0 | 221.0 | 503.6 | 1,896.0 | |
| Implied Stock Price | 0.14 | 0.07 | 0.23 | 0.12 | 0.51 | 0.07 | |
| FX Conversion Rate to Trading Currency | 0.74 | 1.00 | 0.74 | 0.74 | 0.74 | 0.74 | |
| Implied Stock Price (Trading Cur) | 0.19 | 0.07 | 0.32 | 0.16 | 0.69 | 0.10 | |
| Trading Currency | USD | GBP | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 0.74 | 1.00 | 0.74 | 0.74 | 0.74 | 0.74 | |